Elevated Eosinophils in MCAS, POTS, and HEDS

Unsplash Photo

Elevated eosinophils often signal an immune response, but when they appear in the context of complex conditions like Mast Cell Activation Syndrome (MCAS), Postural Orthostatic Tachycardia Syndrome (POTS), and Hypermobile Ehlers-Danlos Syndrome (HEDS), they can create a challenging clinical picture. These three conditions frequently overlap, and understanding how elevated eosinophils influence their symptoms can help patients and healthcare providers better manage care.

Eosinophils are a type of white blood cell involved in the body's immune defense, particularly in allergic reactions and fighting parasitic infections. Normally, eosinophil levels remain low, but when elevated, they can contribute to inflammation and tissue damage.

In MCAS, POTS, and HEDS, elevated eosinophils may not just be a marker but an active player in worsening symptoms. Their presence can indicate ongoing immune system activation, which complicates the management of these disorders.

Mast Cell Activation Syndrome involves inappropriate activation of mast cells, which release histamine and other chemicals causing allergic-like symptoms. Elevated eosinophils often accompany this activation, amplifying inflammation.

• Increased Inflammation: Eosinophils release toxic granules that can damage tissues and worsen inflammation.

• Symptom Overlap: Both mast cells and eosinophils contribute to symptoms like skin rashes, gastrointestinal distress, and respiratory issues.

• Diagnostic Challenges: Elevated eosinophils can confuse diagnosis because they mimic other allergic or autoimmune conditions.

  
  

For example, a patient with MCAS and elevated eosinophils might experience severe itching, swelling, and abdominal pain, which can be mistaken for other allergic diseases. Recognizing the role of eosinophils helps tailor treatments such as antihistamines, corticosteroids, or targeted therapies.

POTS is a disorder of the autonomic nervous system characterized by rapid heart rate upon standing, dizziness, and fatigue. While POTS is primarily neurological, immune system involvement is increasingly recognized.

• Inflammatory Contribution: Elevated eosinophils may contribute to vascular inflammation, affecting blood vessel function and worsening orthostatic intolerance.

• Overlap with Allergic Symptoms: Some POTS patients report allergies or asthma-like symptoms, which may be linked to eosinophil activity.

• Potential for Misdiagnosis: Symptoms like fatigue and brain fog overlap with eosinophil-related inflammation, complicating clinical assessment.

  
  

In practice, a POTS patient with elevated eosinophils might notice worsening dizziness and fatigue during allergic flare-ups. Addressing eosinophil-driven inflammation can improve overall symptom control.

Hypermobile Ehlers-Danlos Syndrome is a connective tissue disorder causing joint hypermobility, pain, and tissue fragility. Though primarily structural, immune dysregulation, including elevated eosinophils, can influence symptom severity.

• Tissue Damage: Eosinophil-related inflammation may exacerbate joint pain and tissue fragility.

• Increased Sensitivity: Patients with HEDS often have heightened sensitivity to pain and inflammation, which eosinophils can worsen.

• Complicated Healing: Elevated eosinophils can delay tissue repair, increasing the risk of chronic pain and injury.

  
  

For example, a person with HEDS and elevated eosinophils might experience prolonged joint swelling after minor injuries, requiring careful management of inflammation alongside physical therapy.

Managing Elevated Eosinophils in the Trifecta

Addressing elevated eosinophils in patients with MCAS, POTS, and HEDS requires a comprehensive approach:

• Accurate Diagnosis: Blood tests measuring eosinophil counts and markers of mast cell activation help clarify the immune status.

• Targeted Medications: Corticosteroids, leukotriene inhibitors, or biologics may reduce eosinophil levels and inflammation.

• Lifestyle Adjustments: Avoiding known allergens, managing stress, and maintaining hydration support immune balance.

• Multidisciplinary Care: Collaboration between immunologists, cardiologists, and rheumatologists ensures all aspects of the trifecta are addressed.

  
  

Patients should work closely with their healthcare team to monitor eosinophil levels and adjust treatments as needed.

• Keep a symptom diary to track flare-ups and possible triggers related to eosinophil activity.

• Discuss with your doctor the possibility of eosinophil-targeted therapies if symptoms persist.

• Maintain a balanced diet rich in anti-inflammatory foods to support immune health.

• Prioritize gentle physical activity that respects joint limitations and avoids overexertion.

• Seek support groups for MCAS, POTS, and HEDS to share experiences and coping strategies.